Cardio Diagnostics Holdings, Inc.
CDIO
$2.88
-$0.06-2.04%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/5/2025
-
GuruFocus
11/5/2025
-
Business Wire
10/28/2025
-
GuruFocus
10/28/2025
-
Business Wire
10/21/2025
-
GuruFocus
10/21/2025
-
Business Wire
7/22/2025
-
Business Wire
7/8/2025
-
Business Wire
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
6/10/2025
-
Business Wire
6/9/2025
-
Yahoo! Finance: News
6/9/2025
-
Insider Monkey
5/29/2025
-
GuruFocus
5/29/2025
-
GuruFocus
5/29/2025
-
Business Wire
5/28/2025
-
TipRanks Financial Blog
5/20/2025
-
Business Wire
5/14/2025
-
TipRanks Financial Blog
5/14/2025
-
TipRanks Financial Blog
5/14/2025
-
The Fly
5/14/2025
-
The Fly
5/12/2025
-
The Fly
5/8/2025
-
GuruFocus
5/8/2025
-
GuruFocus
5/8/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
855 226 9991
Address
311 West Superior Street
Chicago, IL 60654
Chicago, IL 60654
Country
Year Founded
Business Description
Sector
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart...
more